Update Version - View the patch notes and features here. View Patch Notes

Research Articles

A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula


Research Articles

If an investor is going to successfully invest in common stocks over their lifetime, there are three important questions that must be correctly answered. What to invest in? When to invest? When to sell? The first question deals with finding the right company or companies that you believe can deliver the returns you are seeking. […]

Hudson City Bancorp: Short-Term Risk, Long-Term Opportunity?


Research Articles

Hudson City Bancorp (HCBK) is widely recognized as one of the most conservatively and best managed financial institutions in the country. Thanks to their conservative lending practices and prudent fiscal management, Hudson City Bancorp prospered through the great recession while other financial institutions faltered and even collapsed. This prudently run financial institution did not partake […]

Would Ben Graham Give Warren Buffett an ‘F’ for Holding Coca-Cola?


Research Articles

As most everyone knows, Warren Buffett received much of his initial investing education from the father of modern security analysis, the venerable Ben Graham. Personally, I attribute most everything I know about investing from reading the teachings of both Graham and Buffett. To me, it only made sense to learn as much as I could […]

Teva Pharmaceutical Has It All: Value, Growth and Yield


Research Articles

Headquartered in Israel, Teva (TEVA) is the world’s largest generic drug maker, which markets over 1200 molecules in over 60 countries throughout the world. In addition to their generic portfolio, Teva also possesses a strong branded portfolio led by Copaxone, the world’s leading injectable therapy for multiple sclerosis. Teva generates high levels of cash flow, […]

6 High Yield Pharmaceutical Companies: Do They Justify the Risk?


Research Articles

Introduction Today Investors are keenly focused on income while simultaneously very risk averse.This current behavior brings with it a level of frustration.The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows.On the other hand, dividend yields on many blue-chip […]

3 Consecutive Double-Digit Years for the S&P 500?


Research Articles

The question posed by the title of this article is whether or not 2011 will be the third year in a row of double-digit returns for the S&P 500. In calendar year 2009 the S&P 500 returned 26.4% and followed this up in 2010 by earning 15.06%. As we look forward to 2011 we see […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.